/

Business

Math over Myth

Math Over Myth: September Psychedelic Stock News Roundup

,
Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup
Math over Myth

Math Over Myth: MindMed’s Self Destructive Stock Mission

,
Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors
Havn Life Collapses

Math Over Myth: Psychedelic Stock HAVN Life Collapses

,
The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow
Psychedelics in Palliative Care

End of Life: Psychedelics in Palliative Care

,
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care
Math over Myth MindMed

Math Over Myth: Spotlight on MindMed

,
In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers
Math over Myth ATAI Compass

Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS

,
If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
ARK Invest psychedelic

Psychedelic Stocks: ARK Invest and the Reverse Midas Touch

, ,
Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?
Psychedelic Stocks

Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses

,
The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?
MindMed 18-MC Ibogaine Opioid Addiction

MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts Pipeline

,
MindMed drops its proprietary ibogaine for opioid addiction research amidst an ongoing shakeup. What is going on with this psychedelics company?